Pay in 4 interest-free payments of $5.24 Learn more
Ships within 48 hours · Estimated delivery Oct 7 - Oct 12
Although this variability may have introduced an unquantifiable risk of bias, we conducted multiple secondary analysesmost of them prespecifiedwith the aim of mitigating this heterogeneity and improving the clinical applicability of our findings
[1] They are also not recommended during pregnancy or for women planning pregnancy without appropriate consultation with healthcare providers
Efficacy and safety of monotherapy with the novel sodium/glucose cotransporter-2 inhibitor Tofogliflozin in Japanese patients with type 2 diabetes mellitus: a combined phase 2 and 3 randomized, placebo-controlled, double-blind, parallel-group comparative study
Yield: 941 mg, 91%
US$ 25.60
.png?format=pjpeg&width=1600&quality=75&auto=webp)
US$ 20.56
US$ 29.51
US$ 20.61
US$ 24.96
